 |
Jennifer Ying Lan
Ms. Lan is an associate in Davis Polk's Corporate Department, practicing in the Capital Markets Group. She advises both U.S. and foreign issuers and underwriters, including all of the major U.S. investment banks, on capital markets transactions, including initial public offerings and other equity offerings, public and private high-yield, investment-grade and convertible debt offerings and private placements. She also advises clients on general corporate matters, including corporate governance and securities law matters. Her practice ranges across a variety of industries, including biotech, pharmaceutical, mining, financial services, consumer retail and industrials. |
Work Highlights
Recent Initial Public Offerings and Other Capital Markets Transactions
- Completed IPOs for Aprea Therapeutics, Stoke Therapeutics, TransMedics Group, Contura Energy, Magenta Therapeutics, Charah Solutions, Zai Lab and Auris Medical
- Equity offerings for Zai Lab, SACI Falabella, South Jersey Industries, Webster Financial, EnVen Energy, PDC Energy, Hilton, Keryx Pharmaceuticals and Magenta Therapeutics
- Investment grade and high-yield debt offerings for L Brands, Tyson Foods, SACI Falabella, General Dynamics, Schlumberger, Eastman Chemical, Merck, LabCorp, FirstCash, Ingredion, AK Steel, Emerson Electric, General Electric, PDL BioPharma, Penske Truck, West Fraser Timber, MSCI Inc.
- Liability Management for Eastman Chemical, AK Steel, FirstCash, Synergy Pharmaceuticals, HCSC and L Brands
- Acquisition financings for a variety of industries and bank clients
General Corporate:
- Public reporting, securities compliance and corporate governance advice for a variety of large and mid-cap companies and emerging growth companies
Professional History
- Davis Polk since 2013
Practice Focus
Bar Admissions
Education
-
B.A., History, Harvard University, 2007
-
M.B.A., Duke University, Fuqua School of Business, 2013
-
J.D., Duke University School of Law, 2013
Languages
-
Mandarin